510(k) Report

510(k) · Cleared

Cleared

Portable Intensive Care Unit

K012766510(k) TraditionalCleared Jan 23, 2002159-day reviewClass III21 CFR 870.5310

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medical Research Laboratories, Inc. · MKJ Automated External Defibrillators (Non-Wearable)

Cleared on Jan 23, 2002 after a 159-day review. The FDA summary names no predicate by number. 12 later devices descend from it.

Decided
Jan 23, 2002
Review
159 days
Class
Class III
Product code
MKJ
Recalls
None
Predicates
0

12 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2010: 2 descendants cleared2012: 3 descendants cleared2014: 4 descendants cleared2018: 1 descendant cleared2021: 1 descendant cleared2024: 1 descendant cleared200020052010201520202025
  1. This deviceK012766 Portable Intensive Care UnitMedical Research Laboratories, Inc. · 2002
  2. Descendant · cites it directly · 11 of its ownK100654 Zoll Propaq MDZoll Medical Corporation, World Wide Headquarters · 2010
  3. Descendant · 2 generations on · 9 of its ownK102468 Zoll Propaq MDZoll Medical Corporation, World Wide Headquarters · 2010
  4. Descendant · 3 generations on · 8 of its ownK112432 Zoll X SeriesZoll Medical Corporation, World Wide Headquarters · 2012 · Recalled
  5. Descendant · 4 generations on · 4 of its ownK133269 Zoll X SeriesZoll Medical Corporation, World Wide Headquarters · 2014
  6. Descendant · 4 generations on · 3 of its ownK121367 Zoll Propaq XMZOLL Medical Corporation · 2012 · Recalled

Showing 5 of 12 descendants. See all descendants

Descendants cleared per year

2010: 22012: 32014: 42018: 12021: 12024: 1
2010high 4 (2014) · low 0 (2011)2026

Most influential descendants

Showing 5 of 12 · See all
  • K100654Zoll Propaq MDZoll Medical Corporation, World Wide Headquarters · 2010 · cites it directly11descendants
  • K102468Zoll Propaq MDZoll Medical Corporation, World Wide Headquarters · 2010 · 2 generations on9descendants
  • K112432Zoll X SeriesZoll Medical Corporation, World Wide Headquarters · 2012 · 3 generations on8descendants
  • K133269Zoll X SeriesZoll Medical Corporation, World Wide Headquarters · 2014 · 4 generations on4descendants
  • K121367Zoll Propaq XMZOLL Medical Corporation · 2012 · 4 generations on3descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K012766Portable Intensive Care UnitMedical Research Laboratories, Inc.2002—
+1K100654Zoll Propaq MDZoll Medical Corporation, World Wide Headquarters2010—
+2K102468Zoll Propaq MDZoll Medical Corporation, World Wide Headquarters2010—
+3K112432Zoll X SeriesZoll Medical Corporation, World Wide Headquarters20122
+4K133269Zoll X SeriesZoll Medical Corporation, World Wide Headquarters2014—
+4K121367Zoll Propaq XMZOLL Medical Corporation20121

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201020
201230
201440
201810
202110
202410
FIG. 1 — Lineage of K012766, 2002–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MKJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (12)

See all 12

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K100654Zoll Propaq MDZoll Medical Corporation, World Wide Headquarters201011

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K100654 (Zoll Medical Corporation, World Wide Headquarters, 2010) has gone furthest, with 11 descendants of its own.

How does its category compare?

All MKJ devices

MKJ Automated External Defibrillators (Non-Wearable): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MKJ

48in 2025

2007: 72008: 132009: 82010: 42011: 112012: 102013: 72014: 112015: 62017: 42018: 202019: 252020: 522021: 412022: 192023: 242024: 272025: 482026 (partial year): 31
2007high 52 (2020) · low 0 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MKJ

156in 2015

2007: 69 days median2008: 141 days median2009: 165 days median2010: 250 days median2011: 36 days median2012: 197 days median2013: 191 days median2014: 196 days median2015: 156 days median
2007high 250 (2010) · low 36 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MKJ

1in 2025

2007: 122008: 242009: 372010: 352011: 72012: 5, 1 Class I2013: 42014: 24, 15 Class I2015: 12016: 2, 1 Class I2017: 6, 4 Class I2018: 32019: 6, 2 Class I2020: 22021: 42022: 32023: 112024: 52025: 12026 (partial year): 3
2007high 37 (2009) · low 1 (2015)2026

Class I (23 since 2007) Class II/III not classified

Adverse event reports per year · MKJ

13,315in 2025

2007: 3,9582008: 4,7522009: 6,7822010: 7,3992011: 8,1702012: 9,7322013: 14,9552014: 15,3992015: 16,1292016: 17,0622017: 16,6842018: 16,5912019: 16,8612020: 16,1972021: 16,3002022: 14,8672023: 13,7662024: 15,1092025: 13,315
2007high 17,062 (2016) · low 3,958 (2007)2025

MAUDE reports naming product code MKJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007769123,958
200813141244,752
20098165376,782
20104250357,399
2011113678,170
2012101975 (1)9,732
20137191414,955
20141119624 (15)15,399
20156156116,129
20160—2 (1)17,062
20174—6 (4)16,684
201820—316,591
201925—6 (2)16,861
202052—216,197
202141—416,300
202219—314,867
202324—1113,766
202427—515,109
202548—113,315
202631—3—

What is it indicated for?

Without the SAED option, the PIC 2 is intended primarily for use by emergency responders, trained in advanced life support, cardiac care techniques, interpretation of ECG waveforms, and the use of the PIC 2. With the SAED option, the PIC 2 may be used by emergency responders, trained in basic life support, cardiac care techniques, and the use of the PIC 2. The usage may be in an ambulance or at the scene of an emergency. The PIC 2 is also intended for…

Read the full statement (778 words)

Without the SAED option, the PIC 2 is intended primarily for use by emergency responders, trained in advanced life support, cardiac care techniques, interpretation of ECG waveforms, and the use of the PIC 2. With the SAED option, the PIC 2 may be used by emergency responders, trained in basic life support, cardiac care techniques, and the use of the PIC 2. The usage may be in an ambulance or at the scene of an emergency. The PIC 2 is also intended for use by (or on the order of) physicians at the scene of an emergency or in a hospital emergency room, intensive care unit, cardiac care unit, or other similar areas of a hospital. It is also intended to be used during the transport of patients between any of the locations mentioned above. The patient population will consist of adults and children (described below), and will consist of patients both with and without heart dysfunction. The PIC 2 will be used primarily on patients experiencing symptoms of cardiac arrest or in a post trauma situation. [t may also be used whenever it is required to monitor any of those functions that are included (as options) in the device. Indications for each of the specific functions are discussed below:

DEFIBRILLATOR FUNCTION:

The defibrillator function of the PIC 2 is used to treat: ventricular fibrillation and pulseless ventricular tachycardia. The biphasic waveform employed by the PIC 2 has not been clinically tested on pediatric patients The device has not been evaluated for cardioversion of atrial fibrillation or direct (internal) cardiac defibrillation. The semi-automatic mode should not be used on pediatric patients less than 8 years old.

ECG MONITOR FUNCTION:

The ECG monitor function of the PIC 2 is used to monitor and/or record ECG waveform and heart rate, and to alarm when heart rate is above or below limits set by the operator. The PIC 2 also provides output signals for the purpose of sending ECG waveforms to a remote monitor via direct connection, telephone, or radio transmission. Patients may range from neo-natal to aduit.

EXTERNAL TRANSCUTANEOUS PACEMAKER FUNCTION:

The extemnal transcutaneous pacing function of the PIC 2 is used for the emergency treatment of hemodynamically compromising bradycardia, bradycardia with escape rhythms that are unresponsive to pharmacologic therapy, refractory tachycardia (supraventricular or ventricular), and bradyasystolic cardiac arrest. Patients may range from pediatric to aduilt.

NON-INVASIVE BLOOD PRESSURE FUNCTION:

The non-invasive blood pressure function of the PIC 2 is used to make non-invasive measurements of arterial pressure and heart rate, and to alarm if either parameter is outside of the limits set by the user. Measurements are made using an inflatable cuff on the patient's arm or (occasionally) leg. Patients may range from pediatric to adult.

TEMPERATURE MONITOR FUNCTION:

The temperature monitor function of the PIC 2 is used to make continuous measurements of rectal, esophageal, or surface temperature, and to alarm if the temperature is outside of the limits set by the user. It is used on patients ranging from neo-natal to adult.

PULSE OXIMETER FUNCTION:

The pulse oximeter function of the PIC 2 is used to monitor pulse rate and oxygen saturation of arteriolar hemoglobin, and to alarm if either parameter is outside of the limits set by the user. It is used on patients ranging from neo-natal to adult. Measurements are made non-invasively at remote sites such as a finger, toe, ear lobe, bridge of nose, etc. It is used on patients ranging from neo-natal to adult.

RESPIRATION RATE MONITOR FUNCTION:

The respiration rate monitor function of the PIC 2 is used to continuously monitor respiration rate and to alarm if the rate falls outside of the range set by the operator. The patients range from neo-natal to adult. Because the measurement method actuall measures respiratory effort, apnea episodes with continued respiratory effort (such as obstructive apnea) may not be detected. It is not intended to be used as an apnea monitor. It is used on patients ranging from neo-natal to adult.

CO, MONITOR FUNCTION

The respiration rate monitor function of the PIC 2 is used to measure the concentration of carbon dioxide in a gas mixture to aid in determining the patient's ventilatory status. This device is intended as an indicator of patient carbon dioxide concentration during expiration and is not intended as the sole basis for medical diagnosis.

This CO, monitor is intended for use with patients 3 years of age and older. This device is not recommended for patients with low tidal volume such as patients younger than 3 years of age or weighing less than 22 pounds, or patients with a respiration rate greater than or equal to 60 breaths per minute.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K012766: Portable Intensive Care Unit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K012766

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026